fingolimod hydrochloride has been researched along with Colitis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, M; Baeeri, M; Ghafour-Broujerdi, E; Gholami, M; Hassani, S; Mousavi, T; Rahimifard, M; Vakhshiteh, F | 1 |
| Bamias, G; Behrens, EH; Boyer, JD; Clark, D; Gima, L; González-Cabrera, P; Jedlicka, P; Karuppuchamy, T; Peach, R; Rivera-Nieves, J; Rosen, H; Sarkisyan, G; Scott, F; Veny, M | 1 |
| Fujii, T; Kanai, T; Nakamura, T; Nemoto, Y; Okamoto, R; Sakamoto, N; Tomita, T; Totsuka, T; Tsuchiya, K; Watanabe, M | 1 |
| Fujii, T; Watanabe, M | 1 |
| Allegood, JC; Avni, D; Hait, NC; Harikumar, KB; Huang, WC; Kim, EY; Kordula, T; Liang, J; Milstien, S; Nagahashi, M; Price, MM; Spiegel, S; Takabe, K; Yamada, A | 1 |
| Bromberg, JS; Chen, D; Ding, Y; Fu, S; Mao, M; Mao, X; Yopp, AC; Zhang, N | 1 |
| Ito, T; Kai, Y; Kishi, D; Kiyono, H; Matsuda, H; Mizushima, T; Nezu, R; Tamagawa, H | 1 |
| Fujii, R; Kanai, T; Makita, S; Nemoto, Y; Okamoto, R; Oshima, S; Totsuka, T; Tsuchiya, K; Watanabe, M | 1 |
| Andoh, A; Bamba, S; Deguchi, Y; Fujiyama, Y; Inatomi, O; Tsujikawa, T; Yagi, Y | 1 |
| Daniel, C; Geisslinger, G; Radeke, HH; Sartory, N; Stein, JM; Zahn, N | 1 |
10 other study(ies) available for fingolimod hydrochloride and Colitis
| Article | Year |
|---|---|
Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitis.
Topics: Animals; Colitis; Fingolimod Hydrochloride; Inflammatory Bowel Diseases; Myeloid Differentiation Factor 88; Trinitrobenzenesulfonic Acid; Zebrafish | 2022 |
Sphingosine-1-phosphate receptor-1 (S1P
Topics: Animals; Cell Movement; Cells, Cultured; Colitis; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Endothelium; Fingolimod Hydrochloride; Humans; Immunologic Factors; Immunologic Memory; Indans; Inflammatory Bowel Diseases; Intestines; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxadiazoles; Receptors, Lysosphingolipid | 2017 |
FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow.
Topics: Animals; Apoptosis; Bone Marrow; CD4-Positive T-Lymphocytes; Cell Movement; Colitis; Cytokines; Fingolimod Hydrochloride; Lymph Node Excision; Lymphoid Tissue; Lymphotoxin-alpha; Mice; Mice, Inbred C57BL; Propylene Glycols; Sphingosine; Splenectomy | 2008 |
[An additional role of FTY720 in chronic colitis].
Topics: Animals; CD4-Positive T-Lymphocytes; Chronic Disease; Colitis; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mice; Mice, SCID; Propylene Glycols; Sphingosine; T-Lymphocytes | 2009 |
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.
Topics: Animals; Cell Transformation, Neoplastic; Colitis; Colon; Fingolimod Hydrochloride; Gene Deletion; Gene Expression Regulation, Neoplastic; Interleukin-6; Lysophospholipids; Mice; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Sphingosine; STAT3 Transcription Factor; Tumor Microenvironment | 2013 |
CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential.
Topics: Animals; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Division; Cell Movement; Cell Separation; Chemokine CCL19; Chemokine CCL2; Chemokines, CC; Chemotaxis; Colitis; Cytokines; Enzyme-Linked Immunosorbent Assay; Fingolimod Hydrochloride; Flow Cytometry; Gastritis; L-Selectin; Lymphocyte Subsets; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Phenotype; Propylene Glycols; Receptors, CCR2; Receptors, CCR7; Receptors, Chemokine; Receptors, Interleukin-2; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine; T-Lymphocytes; Time Factors | 2004 |
Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis.
Topics: Animals; Apoptosis; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colitis; Disease Models, Animal; Fingolimod Hydrochloride; Flow Cytometry; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Lymphocytes; Mice; Mice, Inbred C57BL; Propylene Glycols; Sphingosine; Tissue Distribution | 2004 |
FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.
Topics: Animals; CD4 Antigens; Colitis; Female; Fingolimod Hydrochloride; Hyaluronan Receptors; Immunologic Memory; Immunosuppressive Agents; Inflammation Mediators; L-Selectin; Mice; Mice, Inbred BALB C; Mice, SCID; Propylene Glycols; Sphingosine | 2006 |
The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Transplantation; Colitis; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; Inflammatory Bowel Diseases; L-Selectin; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Spleen | 2006 |
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
Topics: Animals; Antigens, CD; Antigens, Differentiation; Aziridines; Cell Differentiation; Choline; Colitis; CTLA-4 Antigen; Cytokines; Disease Models, Animal; Down-Regulation; Fingolimod Hydrochloride; Forkhead Transcription Factors; Immunosuppressive Agents; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Neuromuscular Blocking Agents; Propylene Glycols; Sphingosine; T-Lymphocytes, Regulatory; Th1 Cells | 2007 |